Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Magnetic resonance outcome measures in multiple sclerosis trials: time to rethink?
Optic Neuritis and the Visual Pathway: Evaluation of Neuromyelitis Optica Spectrum by Resting-State fMRI and Diffusion Tensor MRI.
Is There A Pulse Wave Encephalopathy Component To Multiple Sclerosis?
The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
Multiple sclerosis in the Southern and Northern hemispheres: the month of birth at different latitudes has the same influence on the prevalence and progression of the disease in the Northern and Southern hemispheres?
TNF-α-mediated anxiety in a mouse model of multiple sclerosis.
Alternative Approaches: A Systematic Review of Non-Pharmacological Treatments for Non-Spastic and Non-Trigeminal Pain in Patients with Multiple Sclerosis.
Linear pontine trigeminal root and trigeminal nerve lesions in multiple sclerosis.
Contribution of spinal cord biopsy to diagnosis of aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.
Reproducibility of multifocal visual evoked potential and traditional visual evoked potential in normal and multiple sclerosis eyes.
Neuro-ophthalmology update.
Assessing the Correlation between Grey and White Matter Damage with Motor and Cognitive Impairment in Multiple Sclerosis Patients.
Dietary Sutherlandia and Elderberry Mitigate Cerebral Ischemia-Induced Neuronal Damage and Attenuate p47phox and Phospho-ERK1/2 Expression in Microglial Cells.
Optic nerve diffusion tensor imaging after acute optic neuritis predicts axonal and visual outcomes.
Diagnosis and management of Neuro-Behçet's disease: international consensus recommendations.
PML: The Dark Side of Immunotherapy in Multiple Sclerosis.
Optic neuritis and the evaluation of visual impairment in multiple sclerosis.
Flow Cytometric Assay Detecting Cytotoxicity against Human Endogenous Retrovirus Antigens Expressed on Cultured Multiple Sclerosis Cells.
Immune reconstitution inflammatory syndrome and natalizumab-Is it possible before removing the drug?
Pathological correlates of magnetic resonance imaging texture heterogeneity in multiple sclerosis.
Chronic pain in multiple sclerosis: Is there also fibromyalgia? An observational study.
Default Network Connectivity Is Linked to Memory Status in Multiple Sclerosis.
Multiple sclerosis: Natalizumab to fingolimod-the washout whitewash.
Optic coherence tomography findings in relapsing-remitting multiple sclerosis patients of the northwest of Iran.
Psychiatric comorbidity in multiple sclerosis: It's not the genes.
Pages
« first
‹ previous
…
384
385
386
387
388
389
390
391
392
…
next ›
last »